Stay updated on Tirzepatide in CKD and Obesity Clinical Trial
Sign up to get notified when there's something new on the Tirzepatide in CKD and Obesity Clinical Trial page.

Latest updates to the Tirzepatide in CKD and Obesity Clinical Trial page
- Check5 days agoNo Change Detected
- Check13 days agoChange DetectedA new revision entry v3.5.2 was added to the history and the previous v3.5.0 entry was removed.SummaryDifference0.1%

- Check20 days agoNo Change Detected
- Check34 days agoChange DetectedRevision history shows the addition of v3.5.0 and the removal of v3.4.3.SummaryDifference0.1%

- Check49 days agoChange DetectedAdded a new revision entry v3.4.3 to the page history, replacing the previous v3.4.2.SummaryDifference0.1%

- Check77 days agoChange DetectedRevision: v3.4.2 was added to the history, and the previous lapse-in-government-funding notice and the v3.4.1 entry were removed.SummaryDifference0.5%

- Check84 days agoChange DetectedAdded a government-funding lapse notice and updated the record history to Revision v3.4.1; the prior Revision v3.4.0 was removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.5%

- Check91 days agoChange DetectedThe UI now includes a glossary toggle and color-coded change indicators (green for additions, red for deletions) with the revision updated to v3.4.0; the No FEAR Act label was updated from 'No FEAR Act data' to 'No FEAR Act Data'.SummaryDifference0.6%

Stay in the know with updates to Tirzepatide in CKD and Obesity Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Tirzepatide in CKD and Obesity Clinical Trial page.